# REVISED Review: Results Section (Option A)
## Focus: Keep Descriptive Language, Remove Discussion Content

---

## REVISED PHILOSOPHY

**✅ KEEP:** Descriptive, comparative, pattern-describing language
**❌ REMOVE:** Clinical implications, pathophysiology explanations, literature connections
**🔧 FIX:** Missing statistics, redundancy, incomplete reporting

---

## SECTION-BY-SECTION REVIEW (REVISED)

---

### **SECTION 3.1: Primary Analysis - MIMIC-IV Data**

#### 📍 **Paragraph 1** (Lines starting with "Table 1 presents...")

**Current Text:**
> "Table 1 presents the comprehensive performance metrics for all four survival models across four imputation methods. Among the evaluated frameworks, the RSF model utilizing GAIN imputation achieved the most robust discrimination performance (CV C-index 0.819; Test C-index 0.754) and demonstrated superior calibration (IBS 0.104) compared to other benchmarks, consistently highlighting the efficacy of ensemble methods over alternative approaches."

**Issues:**
1. ⚠️ **"Highlighting the efficacy of ensemble methods over alternative approaches"** - This is a CONCLUSION/GENERALIZATION → Move to Discussion
2. ⚠️ **Missing context** - Should mention sample size
3. ✅ **"Most robust" and "superior calibration"** - These are FINE for descriptive comparison

**REVISED VERSION:**
> "Table 1 presents the comprehensive performance metrics for all four survival models across four imputation methods applied to the MIMIC-IV cohort (n=852, 59 deaths). Among the evaluated frameworks, the RSF model utilizing GAIN imputation achieved the most robust discrimination performance (CV C-index 0.819, 95% CI: 0.755-0.882; Test C-index 0.754) and demonstrated superior calibration (IBS 0.104) compared to other model-imputation combinations. XGBoost performance ranged from 0.426 to 0.645, DeepSurv from 0.169 to 0.738, and Gradient Boosting from 0.707 to 0.795 across imputation methods."

**What Changed:**
- ✅ Kept "most robust" and "superior" (descriptive comparisons)
- ❌ Removed "highlighting the efficacy of ensemble methods" (generalization/conclusion)
- ✅ Added sample size and context
- ✅ Added specific ranges for comparison
- ✅ Added CI for RSF-GAIN

**Action Items:**
- [x] Keep descriptive language
- [x] Remove generalization about "ensemble methods"
- [x] Add sample size
- [x] Add comparison ranges

---

#### 📍 **Paragraph 2** (Table 2 summary)

**Current Text:**
> "Table 2 summarizes the comparative ranking of all models based on their optimal imputation method. Gradient Boosting with missForest achieved the highest test set discrimination (Test C-index 0.795), followed closely by RSF with GAIN (Test C-index 0.754), which demonstrated the best calibration performance (IBS 0.104). The ensemble methods (Gradient Boosting and RSF) consistently outperformed deep learning (DeepSurv) and gradient boosting variants (XGBoost) across multiple evaluation metrics."

**Issues:**
1. ⚠️ **"Consistently outperformed"** - This is starting to become a CONCLUSION
2. ⚠️ **Missing CIs** - Should report for comparison
3. ✅ **"Followed closely" and "demonstrated the best"** - These are FINE

**REVISED VERSION:**
> "Table 2 summarizes the comparative ranking of all models based on their optimal imputation method. Gradient Boosting with missForest achieved the highest test set discrimination (Test C-index 0.795, 95% CI: 0.725-0.854), followed closely by RSF with GAIN (Test C-index 0.754, 95% CI: 0.755-0.882), which demonstrated the best calibration performance (IBS 0.104). DeepSurv with GAIN achieved a test C-index of 0.738 (95% CI: 0.610-0.781), while XGBoost with MIDA achieved 0.645 (95% CI: 0.674-0.817). Time-dependent AUC at Day 7 was highest for RSF and Gradient Boosting (both 0.946), compared to DeepSurv (1.0) and XGBoost (0.703)."

**What Changed:**
- ✅ Kept "followed closely" and "demonstrated the best" (descriptive)
- ❌ Removed "consistently outperformed" conclusion - replaced with specific values
- ✅ Added all CIs for reader to judge
- ✅ Added specific comparisons with numbers

**Action Items:**
- [x] Keep descriptive comparative language
- [x] Replace conclusion with specific numbers
- [x] Add CIs throughout

---

#### 📍 **Paragraph 3** (Figure 2 description)

**Current Text:**
> "Figure 2 visualizes the discrimination performance (C-index) across all model-imputation combinations. The heatmap pattern reveals that deep learning-based imputation methods (GAIN, MIDA) generally yielded higher C-index values across most models, with RSF and Gradient Boosting showing the most consistent performance regardless of imputation choice. Notably, DeepSurv exhibited high sensitivity to imputation method selection, with performance varying substantially between methods."

**Issues:**
1. ⚠️ **"Generally yielded higher"** - Need more specific description
2. ✅ **"Most consistent" and "high sensitivity"** - These are FINE for describing patterns
3. ⚠️ **"Varying substantially"** - Should quantify

**REVISED VERSION:**
> "Figure 2 visualizes the discrimination performance (C-index) across all 16 model-imputation combinations. The heatmap pattern shows that deep learning-based imputation methods (GAIN, MIDA) generally yielded higher C-index values across most models, with RSF and Gradient Boosting showing the most consistent performance regardless of imputation choice (RSF range: 0.671-0.754, difference 0.083; Gradient Boosting range: 0.707-0.795, difference 0.088). Notably, DeepSurv exhibited high sensitivity to imputation method selection, with performance varying substantially between methods (range: 0.169-0.738, difference 0.569)."

**What Changed:**
- ✅ Kept descriptive language ("generally yielded", "most consistent", "high sensitivity")
- ✅ Added specific ranges to quantify the patterns
- ✅ More precise while maintaining readability

**Action Items:**
- [x] Keep pattern-describing language
- [x] Add specific numbers to support descriptions
- [x] Quantify "substantially"

---

### **SECTION 3.1.1: Random Survival Forest Performance**

#### 📍 **Paragraph 1** (Figure 3 description)

**Current Text:**
> "Figure 3 illustrates the calibration of the RSF model. The model demonstrates reasonable agreement between predicted risk deciles and observed event rates, indicating reliable risk stratification capabilities for clinical use."

**Issues:**
1. ❌ **"Indicating reliable risk stratification capabilities for clinical use"** - This is CLINICAL IMPLICATION → Must move to Discussion
2. ⚠️ **"Reasonable agreement"** - Could be more specific
3. ✅ **General structure is fine**

**REVISED VERSION:**
> "Figure 3 illustrates the calibration of the RSF model. The model demonstrates good agreement between predicted risk deciles and observed event rates, with the calibration curve closely following the diagonal (perfect calibration line) for the lower to middle risk deciles. Across the 10 risk deciles, predicted risk ranged from 0.01 to 0.21, while observed event rates ranged from 0.0 to 0.22, showing close correspondence between predictions and outcomes."

**What Changed:**
- ❌ Removed clinical implications statement (save for Discussion)
- ✅ Kept "demonstrates good agreement" (descriptive)
- ✅ Added specific ranges from the figure
- ✅ Described the pattern more precisely

**Action Items:**
- [x] Remove clinical implications
- [x] Keep descriptive assessment
- [x] Add quantitative details

---

#### 📍 **Paragraph 2** (Variable importance introduction)

**Current Text:**
> "We evaluated the importance of clinical features in predicting sepsis mortality using permutation importance from the RSF model (Primary Analysis)."

**Assessment:**
✅ **This is fine as-is** - Brief, factual, appropriate transition

**NO CHANGES NEEDED**

---

#### 📍 **Paragraph 3** (Table 3 interpretation)

**Current Text:**
> "Table 3 presents the top 10 predictive features identified by RSF. Consistent with clinical expectations, Platelet Count ("Plt") and Glasgow Coma Scale ("GCS") emerged as the most significant predictors."

**Issues:**
1. ❌ **"Consistent with clinical expectations"** - This is DISCUSSION content (connecting to clinical knowledge)
2. ✅ **"Emerged as the most significant"** - This is FINE (descriptive)

**REVISED VERSION:**
> "Table 3 presents the top 10 predictive features identified by RSF. Platelet Count ("Plt") emerged as the most significant predictor with an importance of 0.1383 (±0.0463), followed by Glasgow Coma Scale ("GCS") at 0.0552 (±0.0142) and Lactate at 0.0281 (±0.0173). The importance of platelet count was 2.5-fold higher than GCS and 4.9-fold higher than lactate, indicating substantially greater predictive contribution."

**What Changed:**
- ❌ Removed "consistent with clinical expectations" (save for Discussion)
- ✅ Kept "emerged as most significant" (descriptive ranking)
- ✅ Added specific values and quantified differences

**Action Items:**
- [x] Remove clinical knowledge connections
- [x] Keep ranking/pattern language
- [x] Add specific importance values

---

### **SECTION 3.1.2: Key Predictive Variables**

**Current Text:**
> "As shown in Figure 4 and Table 3, "Platelet count" and "Lactate" levels were consistently identified as top predictors. This aligns with the pathophysiology of sepsis-induced coagulopathy and shock. Other important variables included "Respiratory Rate" and "GCS", highlighting the importance of hemodynamic and neurological status in prognosis."

**Issues:**
1. ❌ **"This aligns with the pathophysiology..."** - DISCUSSION content
2. ❌ **"Highlighting the importance of...in prognosis"** - DISCUSSION/INTERPRETATION
3. ⚠️ **Redundant with 3.1.1** - Already discussed these variables

**RECOMMENDATION:**

**Option 1: DELETE THIS SECTION ENTIRELY** (Preferred)
- It's redundant with 3.1.1
- The pathophysiology belongs in Discussion
- No new information is added

**Option 2: REWRITE to show consistency across imputation methods**

If you want to keep it, here's a better version:

> "Figure 4 displays variable importance rankings across all four imputation methods. Platelet count and lactate consistently ranked among the top three predictors across all imputation strategies (MICE, missForest, GAIN, MIDA), demonstrating robust importance regardless of missing data handling approach. Similarly, respiratory rate and GCS consistently ranked in the top five across all methods."

**What This Would Show:**
- ✅ Adds NEW information (consistency across imputation methods)
- ✅ Descriptive pattern
- ❌ Removes pathophysiology discussion

**Action Items:**
- [ ] **RECOMMENDED: Delete this section entirely**
- [ ] OR: Rewrite to show cross-method consistency
- [ ] Move pathophysiology to Discussion

---

### **SECTION 3.1.3: Survival Analysis and Risk Stratification**

**Current Text:**
> "RSF-predicted risk scores were used to stratify patients into high- and low-risk groups (median split). Figure 5 displays the Kaplan-Meier survival curves for these groups. The high-risk group showed significantly lower survival probability compared to the low-risk group (Log-rank p < 0.001), confirming the model's ability to effectively stratify patient risk."

**Issues:**
1. ❌ **"Confirming the model's ability to effectively stratify"** - This is CONCLUSION language
2. ⚠️ **Missing survival probabilities** at key timepoints
3. ⚠️ **Missing hazard ratio**
4. ⚠️ **Missing group sizes**
5. ✅ **"Showed significantly lower"** - This is FINE (describes the result)

**REVISED VERSION:**
> "RSF-predicted risk scores were used to stratify patients into high-risk (n=426) and low-risk (n=426) groups via median split. Figure 5 displays the Kaplan-Meier survival curves for these groups. The high-risk group showed significantly lower survival probability compared to the low-risk group throughout the follow-up period. At 30 days, survival probability was 0.XX (95% CI: X-X) for the high-risk group versus 0.XX (95% CI: X-X) for the low-risk group. At 60 days, survival probabilities were 0.XX and 0.XX, respectively. The groups showed clear separation with a log-rank test p < 0.001 and hazard ratio of X.XX (95% CI: X-X, p < 0.001) for high-risk versus low-risk patients."

**What Changed:**
- ❌ Removed "confirming the model's ability" (conclusion)
- ✅ Kept "showed significantly lower" (descriptive result)
- ✅ Added sample sizes, survival probabilities, and hazard ratio
- ✅ More complete statistical reporting

**Action Items:**
- [x] Remove conclusion language
- [x] Keep descriptive comparative language
- [ ] Add survival probabilities (need to extract from your data)
- [ ] Add hazard ratio (need to calculate)
- [x] Add group sizes

---

### **SECTION 3.2: Missing Data Imputation**

#### 📍 **Paragraph 1**

**Current Text:**
> "Missing data analysis revealed distinct patterns across clinical variables (Table B2, Appendix A2). Liver function tests ("ALT", "AST") and vital signs ("GCS", "HR", "RR") exhibited extensive missingness (≈ 56–57%), whereas electrolytes ("Cl", "Na") and "platelet counts" showed minimal missing data rates (≈ 7%)."

**Issues:**
1. ⚠️ **Location** - Should be at beginning of Section 3.1, not here
2. ✅ **Language is fine** - "Revealed distinct patterns" and "exhibited" are appropriate descriptive language
3. ⚠️ **Section organization** - This section should focus on imputation PERFORMANCE, not missingness patterns

**REVISED APPROACH:**

**Move this to Section 3.1** (before Table 1) and retitle current 3.2 to focus on imputation performance.

**Keep the language as-is** - it's appropriately descriptive.

**Action Items:**
- [ ] Move to beginning of Section 3.1
- [ ] No language changes needed (it's fine)
- [ ] Retitle 3.2 to "Imputation Method Performance"

---

#### 📍 **Paragraph 2**

**Current Text:**
> "The choice of imputation method notably influenced downstream model efficacy (Table 1). The deep learning-based GAIN method consistently supported robust discrimination, particularly for RSF (CV C-index 0.819; 95% CI 0.745–0.892). While classical methods like missForest also yielded competitive results (CV C-index 0.810 for RSF; 0.790 for Gradient Boosting), GAIN delivered the highest generalization performance on the independent test set for the primary RSF model (0.754). Visual quality assessment (Figure B1, Appendix A2) confirmed that the imputation algorithms generally preserved the underlying data distributions, with key variables like Lactate showing close alignment between imputed and observed densities."

**Issues:**
1. ⚠️ **CI error**: "95% CI 0.745–0.892" should be "0.755-0.882" (check Table 1)
2. ❌ **"Confirmed that... preserved"** - Too strong; better: "showed that..."
3. ✅ **"Notably influenced", "consistently supported", "competitive results", "delivered highest"** - All FINE
4. ⚠️ **Figure B1 description** - Could be more specific

**REVISED VERSION:**
> "The choice of imputation method notably influenced downstream model performance (Table 1). The deep learning-based GAIN method consistently supported robust discrimination, particularly for RSF (CV C-index 0.819; 95% CI 0.755–0.882; Test C-index 0.754). While classical methods like missForest also yielded competitive results (CV C-index 0.810 for RSF, Test C-index 0.710; CV C-index 0.790 for Gradient Boosting, Test C-index 0.795), GAIN achieved the highest test set performance for RSF among all imputation methods tested. Visual inspection of imputed data quality (Figure B1, Appendix A2) showed that the imputation algorithms generally preserved the underlying data distributions, with key variables like Lactate showing close alignment between imputed and observed density curves (median imputed vs. observed: MICE X.X vs. X.X, missForest X.X vs. X.X, GAIN X.X vs. X.X, MIDA X.X vs. X.X)."

**What Changed:**
- ✅ Kept descriptive language ("notably influenced", "consistently supported", "competitive")
- 🔧 Fixed CI error
- ✅ Changed "confirmed" to "showed" (less assertive)
- ✅ Added test set values for missForest
- ✅ More specific Figure B1 description

**Action Items:**
- [x] Keep descriptive comparative language
- [x] Fix CI error
- [x] Add test set values for comparison
- [ ] Add specific values from Figure B1 (need to extract)

---

### **SECTION 3.3: Sensitivity Analysis - Imputation Methods**

#### 📍 **Paragraph 1**

**Current Text:**
> "We assessed the robustness of our primary model (RSF) by systematically comparing performance across imputation methods under three simulated missingness mechanisms (Table 4). GAIN consistently achieved the highest discrimination across all mechanisms (C-index ≈ 0.84–0.85), demonstrating superior robustness compared to MICE and missForest, which exhibited significant performance degradation, particularly under non-random (MNAR) conditions. MIDA also demonstrated strong resilience, especially in the challenging MNAR setting (C-index 0.819). The comprehensive time-dependent AUC results across all mechanisms are detailed in Table 5 and visually summarized in Figure D2 (Appendix D)."

**Issues:**
1. ⚠️ **"Demonstrating superior robustness"** - On the edge, but acceptable for Option A
2. ⚠️ **"Significant performance degradation"** - "Significant" has statistical meaning; be more specific
3. ⚠️ **"Strong resilience" and "challenging"** - Could be more precise
4. ✅ **"Consistently achieved"** - FINE
5. ⚠️ **Need more specific numbers**

**REVISED VERSION:**
> "We assessed the robustness of our primary model (RSF) by systematically comparing performance across imputation methods under three simulated missingness mechanisms (Table 4). GAIN consistently achieved the highest discrimination across all mechanisms (C-index range: 0.838–0.850, difference: 0.012), demonstrating superior stability compared to MICE and missForest. MICE showed the largest performance variation across mechanisms (C-index range: 0.539-0.612, difference: 0.073), while missForest ranged from 0.582 to 0.682 (difference: 0.100). MIDA also demonstrated strong performance stability, particularly under MNAR conditions (C-index 0.819), with an overall range of 0.686-0.819 (difference: 0.133). The comprehensive time-dependent AUC results across all mechanisms are detailed in Table 5 and visually summarized in Figure D2 (Appendix D)."

**What Changed:**
- ✅ Kept "superior", "robustness", "strong" (descriptive comparisons)
- ✅ Replaced "significant degradation" with specific ranges
- ✅ Added specific numbers for all methods
- ✅ Quantified "stability" with actual ranges

**Action Items:**
- [x] Keep descriptive comparative language
- [x] Add specific ranges for all methods
- [x] Replace vague terms with numbers

---

#### 📍 **Paragraph 2** (Table 5 description)

**Current Text:**
> "Table 5 presents the time-dependent discrimination performance across all evaluated models and data scenarios. For the real MIMIC-IV data, Gradient Boosting achieved the highest early discrimination at Days 3 and 7 (AUC 0.977 and 0.962, respectively), while maintaining competitive performance at Day 14 (AUC 0.617). Under simulated missingness conditions, RSF demonstrated the most consistent time-dependent performance, particularly excelling in the MCAR scenario (Day 7 AUC 0.971) and maintaining robust discrimination even under challenging MNAR conditions (Day 14 AUC 0.883). This pattern underscores the ensemble method's stability across varying data quality scenarios."

**Issues:**
1. ❌ **"This pattern underscores the ensemble method's stability..."** - This is CONCLUSION/GENERALIZATION → Move to Discussion
2. ⚠️ **"Challenging"** - Subjective
3. ✅ **"Highest", "competitive", "most consistent", "excelling", "robust"** - All FINE for Option A
4. ⚠️ **Need more systematic comparison**

**REVISED VERSION:**
> "Table 5 presents the time-dependent discrimination performance across all evaluated models and data scenarios. For the real MIMIC-IV data, Gradient Boosting achieved the highest early discrimination at Days 3 and 7 (AUC 0.977 and 0.962, respectively), while maintaining competitive performance at Day 14 (AUC 0.617). RSF showed high discrimination at Days 3 and 7 (AUC 0.960 and 0.943), with lower discrimination at Day 14 (AUC 0.531).

> Under simulated missingness conditions, RSF demonstrated the most consistent time-dependent performance across mechanisms. At Day 7, RSF achieved AUC values of 0.971 (MCAR), 0.902 (MAR), and 0.899 (MNAR), showing relatively stable discrimination (range: 0.071). In comparison, Gradient Boosting showed greater variability (Day 7 AUC: 0.916 MCAR, 0.857 MAR, 0.775 MNAR; range: 0.141). XGBoost showed similar variability (range: 0.198), while DeepSurv showed moderate variation (range: 0.128). At Day 14 under MNAR conditions, RSF maintained the highest discrimination (AUC 0.883) among all models tested."

**What Changed:**
- ❌ Removed "This pattern underscores..." conclusion
- ✅ Kept descriptive comparative language
- ✅ Added systematic comparison with ranges
- ✅ More complete reporting of all models

**Action Items:**
- [x] Remove conclusion sentence
- [x] Keep descriptive language
- [x] Add systematic ranges for all models

---

## SUMMARY OF REVISED RECOMMENDATIONS

### **KEEP (Appropriate for Option A):**
✅ "Most robust", "superior", "highest", "best"
✅ "Consistently achieved", "demonstrated", "showed"
✅ "Competitive", "strong", "excellent"
✅ "Most consistent", "high sensitivity", "substantial variation"
✅ Pattern descriptions and comparative language

### **REMOVE (Discussion Content):**
❌ "This aligns with pathophysiology..."
❌ "Consistent with clinical expectations..."
❌ "Indicating reliable risk stratification for clinical use..."
❌ "Confirming the model's ability..."
❌ "Highlighting the efficacy/importance of..."
❌ "This pattern underscores..."
❌ Any generalization beyond your specific results

### **ADD (Missing Information):**
📊 Sample sizes for subgroups
📊 Specific ranges when describing variability
📊 Survival probabilities at key timepoints
📊 Hazard ratios
📊 Specific values from figures
📊 Confidence intervals consistently

### **FIX (Errors):**
🔧 CI mismatch in Section 3.2
🔧 Section organization (move missingness patterns)
🔧 Redundancy in Section 3.1.2

---

## KEY SECTIONS TO REVISE

### **Priority 1 - Must Fix:**
1. ✅ Section 3.1.1 Para 1 - Remove "indicating reliable...for clinical use"
2. ✅ Section 3.1.2 - DELETE entirely OR rewrite to show cross-method consistency
3. ✅ Section 3.1.3 - Remove "confirming", add survival probabilities and HR
4. ✅ Section 3.3 Para 2 - Remove "This pattern underscores..." sentence
5. 🔧 Section 3.2 Para 2 - Fix CI error

### **Priority 2 - Should Improve:**
1. ✅ Section 3.1 Para 1 - Remove "highlighting the efficacy of ensemble methods"
2. ✅ Section 3.1.1 Para 3 - Remove "Consistent with clinical expectations"
3. ✅ Section 3.2 Para 1 - Move to beginning of Section 3.1
4. ✅ Throughout - Add more specific numbers supporting descriptive statements

### **Priority 3 - Optional Enhancement:**
1. Add cohort characteristics at beginning of Section 3.1
2. Add more quantitative details to Figure descriptions
3. Calculate hazard ratio for risk stratification

---

## SPECIFIC DELETIONS

### **Delete These Exact Phrases:**
1. "highlighting the efficacy of ensemble methods over alternative approaches"
2. "Consistent with clinical expectations,"
3. "indicating reliable risk stratification capabilities for clinical use"
4. "This aligns with the pathophysiology of sepsis-induced coagulopathy and shock."
5. "highlighting the importance of hemodynamic and neurological status in prognosis"
6. "confirming the model's ability to effectively stratify patient risk"
7. "This pattern underscores the ensemble method's stability across varying data quality scenarios."

### **Replace "confirmed" with "showed":**
- "confirmed that the imputation algorithms" → "showed that the imputation algorithms"

---

## ESTIMATED REVISION TIME

With Option A approach (less strict):

**Priority 1 fixes:** 2-3 hours
**Priority 2 improvements:** 1-2 hours  
**Priority 3 enhancements:** 2-3 hours

**Total: 5-8 hours** (much less than original 10 hours)

---

## BOTTOM LINE

Your sensei wants you to:
✅ **Keep descriptive comparative language** - "superior", "highest", "most consistent", "robust"
✅ **Describe patterns clearly** - Help readers see what the data shows
✅ **Make results accessible** - Not just raw numbers

But still:
❌ **No clinical implications** in Results - save for Discussion
❌ **No pathophysiology explanations** - save for Discussion  
❌ **No conclusions about what it all means** - save for Discussion

**The main changes are:**
1. Delete 7 specific concluding phrases (listed above)
2. Fix the CI error
3. Add missing statistical details (HR, survival probabilities)
4. Consider deleting/rewriting Section 3.1.2

Everything else is fine!
